Corient Private Wealth’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.72M Buy
16,988
+1,358
+9% +$141K ﹤0.01% 1487
2026
Q1
$1.5M Sell
15,630
-1,866
-11% -$191K ﹤0.01% 1412
2025
Q4
$1.86M Sell
17,496
-2,313
-12% -$268K ﹤0.01% 1194
2025
Q3
$2.52M Sell
19,809
-600
-3% -$71.4K ﹤0.01% 966
2025
Q2
$2.5M Buy
20,409
+3,721
+22% +$425K ﹤0.01% 939
2025
Q1
$1.69M Buy
16,688
+725
+5% +$70.8K ﹤0.01% 1035
2024
Q4
$1.47M Sell
15,963
-4,270
-21% -$419K ﹤0.01% 1128
2024
Q3
$1.96M Buy
20,233
+3,452
+21% +$310K ﹤0.01% 1107
2024
Q2
$1.44M Sell
16,781
-237
-1% -$19.9K ﹤0.01% 1180
2024
Q1
$1.41M Sell
17,018
-59
-0.3% -$4.32K ﹤0.01% 1189
2023
Q4
$1.14M Buy
17,077
+11,130
+187% +$721K ﹤0.01% 1232
2023
Q3
$399K Buy
5,947
+71
+1% +$4.88K ﹤0.01% 1609
2023
Q2
$398K Buy
5,876
+52
+0.9% +$3.26K ﹤0.01% 1566
2023
Q1
$315K Buy
+5,824
New +$339K ﹤0.01% 1586

Other funds holding EHC

Corient Private Wealth's EHC Position: Q2 2026 in Review

Corient Private Wealth increased its Encompass Health (EHC) stake by 8.7% in Q2 2026, buying an estimated $141K and bringing the position to 16,988 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #1487.

Corient Private Wealth first reported a position in EHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $2.52M in Q3 2025. 597 funds tracked by Wall St. Rank hold EHC as of Q2 2026.

  • Corient Private Wealth held 16,988 shares of Encompass Health worth $1.72M as of Q2 2026.
  • Corient Private Wealth bought 1,358 Encompass Health shares in Q2 2026, an estimated $141K.
  • Encompass Health made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1487 holding.
  • Corient Private Wealth first reported a position in Encompass Health in Q1 2023 and has held it in 14 quarters since.
  • Corient Private Wealth's Encompass Health position peaked at $2.52M in Q3 2025.
  • 597 funds tracked by Wall St. Rank held Encompass Health as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.